Choroidal neovascularization secondary to sorsby fundus dystrophy treated with intravitreal bevacizumab.
OBJECTIVE
To report a case of extrafoveal choroidal neovascularization secondary to Sorsby fundus dystrophy that maintained 20/20 visual acuity over 14 months with intravitreal bevacizumab therapy.


METHODS
Interventional case report of as-needed treatment with intravitreal bevacizumab of a 38-year-old lady with choroidal neovascularization from Sorsby fundus dystrophy.


RESULTS
Three injections of intravitreal bevacizumab were given over 14.5 months, maintaining visual acuity at 20/20.


CONCLUSIONS
Intravitreal bevacizumab therapy appears to maintain vision in patients with choroidal neovascularization from Sorsby fundus dystrophy.
*South Australian Institute of Ophthalmology, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia †Marion Road Eye Clinic, Plympton Park, South Australia.
Tim L
TL
Gray
Hong-Chai
HC
Wong
Grant L
GL
Raymond